GenoGra
PrivateLast Round
Pre Seed
Feb 16, 2026
Total Funding Raised
$1.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GenoGra operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Pre Seed round in February 2026.
GenoGra is a biotechnology company that develops a pangenomic software platform designed for faster and more accurate interpretation of genetic data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoGra Comparables
Compare GenoGra with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Basepair Inc | 72% | |
| Velsera | 71% | |
| Illumina, Inc. | 69% |
For institutional investors. Book with your work email.
GenoGra Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenoGra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Intesa Sanpaolo Innovation Center | Pre Seed |
| European Investment Fund | Pre Seed |
| Terra Next Accelerator | Pre Seed |
| Maia Ventures | Pre Seed |
| CDP Venture Capital SGR | Pre Seed |
| PM Holding | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Grew 63% QoQ, from 8 to 13 employees.
- Apr 6, 2026
Monthly visitors increased 191% MoM.
For institutional investors. Book with your work email.
GenoGra Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenoGra's valuation, stock price, and market status.
Is GenoGra a public or private company?
GenoGra is a private company.
What is the current stock price of GenoGra?
GenoGra is a private company, so its shares have no public market price. Caplight tracks GenoGra's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenoGra worth (valuation)?
Valuation information for GenoGra is not publicly available.
Can I buy GenoGra stock?
GenoGra shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenoGra's last funding round?
GenoGra's most recent funding round was Pre Seed on February 16, 2026.
Who are the main investors in GenoGra?
Key investors in GenoGra include Maia Ventures.
Will GenoGra IPO soon?
No public IPO plans have been announced for GenoGra.
How can I track GenoGra secondary market activity?
Caplight tracks bids, offers, and trades in GenoGra's shares on secondary markets.